1.70BMarket Cap-8.72P/E (TTM)
15.400High14.160Low2.46MVolume14.200Open13.930Pre Close36.33MTurnover2.92%Turnover RatioLossP/E (Static)117.04MShares15.79052wk High10.88P/B1.23BFloat Cap3.11052wk Low--Dividend TTM84.30MShs Float40.880Historical High--Div YieldTTM8.90%Amplitude1.760Historical Low14.763Avg Price1Lot Size
Arcutis Biotherapeutics Stock Forum
Arcutis Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rubric Capital Management LP(9.38%),David Rosen(9.38%)
Long-term! 😜
1 MINUTE AGO, 8:20 AM EDT
VIA GLOBENEWSWIRE
New Data Shows ZORYVE® (Roflumilast) Cream 0.15% Provided Consistent Improvement of Atopic Dermatitis in Individuals With Diverse Skin Types | ARQT Stock News
No comment yet